This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Uniwersytet Lodzki. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ł ódź, PL (2018)
- Lódż, PL (2018)
Company Filing History:
Years Active: 2018
Title: Maria Bryszewska: Innovator in Dendrimer Technology
Introduction
Maria Bryszewska is a prominent inventor based in Łódź, Poland. She has made significant contributions to the field of dendrimer technology, particularly in the development of innovative drug delivery systems. With a total of 2 patents, her work focuses on addressing critical health challenges.
Latest Patents
One of her latest patents is titled "Application of maltotriose-coated 4th generation poly(propyleneimine) dendrimer PPI-G4-OS-Mal-III." This invention relates to a method of administering a fourth-generation polypropyleneimine dendrimer, which is coated with maltotriose. The dendrimer, designated as PPI-G4-OS-Mal-III, contains 25 to 45% of R substituents that represent maltotriose residues, while the remaining R substituents are hydrogen. This innovative approach aims to enhance drug delivery to human subjects. Another significant patent by Bryszewska involves the application of the maltotriose-coated dendrimer for treating neoplastic proliferation diseases, particularly chronic lymphocytic leukemia.
Career Highlights
Maria Bryszewska is affiliated with the University of Łódź, where she conducts her research and development activities. Her academic background and research expertise have positioned her as a leading figure in her field.
Collaborations
She collaborates with notable colleagues, including Ida Franiak-Pietryga and Dietmar Appelhans, to advance her research initiatives and explore new applications for her inventions.
Conclusion
Maria Bryszewska's innovative work in dendrimer technology showcases her commitment to improving healthcare solutions. Her patents reflect her dedication to addressing significant medical challenges through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile